Literature DB >> 31093709

Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CT.

Aurélie Moreau1,2, Anne Laure Giraudet3, Thomas Mognetti3, David Kryza4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31093709     DOI: 10.1007/s00259-019-04352-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  (18)F-FDG PET/CT in patients with idiopathic retroperitoneal and mediastinal fibrosis.

Authors:  R Fernández-López; J A Lojo; I Acevedo-Báñez; R González-León; I Borrego-Dorado
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-01       Impact factor: 9.236

2.  [18F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study.

Authors:  Archie Fernando; James Pattison; Catherine Horsfield; David D'Cruz; Gary Cook; Tim O'Brien
Journal:  Eur Urol       Date:  2016-11-18       Impact factor: 20.096

Review 3.  Idiopathic Retroperitoneal Fibrosis.

Authors:  Augusto Vaglio; Federica Maritati
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

Review 4.  FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.

Authors:  Nicolas Aide; Rodney J Hicks; Christophe Le Tourneau; Stéphanie Lheureux; Stefano Fanti; Egesta Lopci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-05       Impact factor: 9.236

  4 in total
  1 in total

1.  Case Report: A Programmed Cell Death-1 Inhibitor-Related Abdominal Fibroinflammatory Reaction Affecting Multiple Organs in A Non-Small-Cell Lung Cancer Patient.

Authors:  An-Tian Chen; Yue-Quan Shi; Bei Tan; Liang Zhu; Ya-Ping Luo; Wei Zhong; Meng-Zhao Wang; Yan Xu
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.